90 related articles for article (PubMed ID: 9990450)
1. Synthesis and methemoglobin toxicity of the amides of 6/7 mono or disubstituted quinolone.
Srivastava S; Srivastava SK; Shukla A; Chauhan PM; Puri SK; Bhaduri AP; Pandey VC
Bioorg Med Chem Lett; 1999 Jan; 9(1):25-30. PubMed ID: 9990450
[TBL] [Abstract][Full Text] [Related]
2. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
[TBL] [Abstract][Full Text] [Related]
3. A simple and rapid evaluation of methemoglobin toxicity of 8-aminoquinolines and related compounds.
Srivastava P; Singh S; Jain GK; Puri SK; Pandey VC
Ecotoxicol Environ Saf; 2000 Mar; 45(3):236-9. PubMed ID: 10702341
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility to norfloxacin of some bacterial strains causing urinary infections].
Tuchiluş C; Poiată A; Bădicuţ I; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):383-6. PubMed ID: 16607805
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Børsum T; Dannevig L; Størvold G; Melby K
Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
[TBL] [Abstract][Full Text] [Related]
8. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
9. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
Lafredo SC; Foleno BD; Fu KP
Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
[TBL] [Abstract][Full Text] [Related]
10. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.
Hoffner SE; Kratz M; Olsson-Liljequist B; Svenson SB; Källenius G
J Antimicrob Chemother; 1989 Sep; 24(3):317-24. PubMed ID: 2808189
[TBL] [Abstract][Full Text] [Related]
11. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
12. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
Allemandi DA; Alovero FL; Manzo RH
J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
[TBL] [Abstract][Full Text] [Related]
14. 4-quinolones inhibit biotransformation of caffeine.
Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
[TBL] [Abstract][Full Text] [Related]
15. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
Rahal K
Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
[TBL] [Abstract][Full Text] [Related]
16. Methemoglobin reductase activity and in vitro sensitivity towards oxidant induced methemoglobinemia in swiss mice and beagle dogs erythrocytes.
Srivastava S; Alhomida AS; Siddiqi NJ; Puri SK; Pandey VC
Mol Cell Biochem; 2002 Mar; 232(1-2):81-5. PubMed ID: 12030383
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity.
Ramadan MA; Tawfik AF; el-Kersh TA; Shibl AM
J Infect Dis; 1995 Feb; 171(2):483-6. PubMed ID: 7844396
[TBL] [Abstract][Full Text] [Related]
19. Post-antibiotic effect of quinolones on Pseudomonas aeruginosa.
Sood P; Mandal A; Mishra B
J Antimicrob Chemother; 1999 Mar; 43(3):425-7. PubMed ID: 10223604
[No Abstract] [Full Text] [Related]
20. Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
Sakurai N; Sano M; Hirayama F; Kuroda T; Uemori S; Moriguchi A; Yamamoto K; Ikeda Y; Kawakita T
Bioorg Med Chem Lett; 1998 Aug; 8(16):2185-90. PubMed ID: 9873510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]